Biotoxtech
Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.
3 contract research organizations in our directory list Carcinogenicity Studies as a capability, across 3 countries. 3 report GLP capability and 1 reports AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.
Showing 3 CROs. Order rotates daily so no lab is permanently listed first.
Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.
Long-established Japanese preclinical CRO providing toxicology, carcinogenicity, genetic toxicity and pharmacology studies.
Independent German preclinical CRO conducting GLP toxicology, reproductive toxicology, carcinogenicity and safety pharmacology studies across rodent and non-rodent species.